Grosshansdorf, Germany

Olaf Holz

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.v., The Board of Regents of the University of Nebraska. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olaf Holz. Retrieved from https://idiyas.com/inventor/olaf-holz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olaf Holz: Inventor in Inflammatory and Fibrotic Disease Research.

Introduction

Olaf Holz is an inventor based in Grosshansdorf, Germany. His work includes a patent concerning the diagnosis and treatment of inflammatory disorders and fibrotic disease.

Latest Patents

Holz is associated with 1 patent: “Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease.” The patent describes compositions and methods for diagnosing and treating inflammatory diseases and disorders, including pulmonary diseases and fibrotic disorders such as COPD.

Career Highlights

Holz’s listed organizational affiliations include the Board of Regents of the University of Nebraska and Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.

Collaborations

His listed collaborators include Stephen I. Rennard and Xiang-der Liu.

Conclusion

Olaf Holz’s patent work focuses on approaches to diagnosing and treating inflammatory and fibrotic diseases, including COPD.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…